Stealthy Biotech Revives Stalled Parkinsons Drug Reveals Plans In Alzheimers and ALS

Aug 25, 2016, 17:19 PM by Michael Croft

Forbes | Denali Therapeutics, the stealthy South San Francisco biotech startup that raised $217 million last year to fight Alzheimer's, Parkinson's and ALS, is finally lifting the curtain on its plans this morning.

August 25, 2016 | Denali Therapeutics, the stealthy South San Francisco biotech startup that raised $217 million last year to fight Alzheimer's, Parkinson's and ALS, is finally lifting the curtain on its plans this morning. Forbes